ZLAB today
$26.04-$0.38 (-1.44%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourBearish
1 hourSymmetric Triangle
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns up above $25.50
Key levels
Resistance$29.02
Resistance$27.14
Support$25.50
Support$23.71
Latest news & SEC filings
SEC FilingZai Lab Ltd filed a report on a major company event (Form 8-K)
EarningsZai Lab posts narrower quarterly loss as revenue tops estimates
All ZLAB news →About Zai Lab
Zai Lab is a commercial-stage biopharmaceutical company that discovers, develops, and commercializes therapies for oncology, immunology, neuroscience, and infectious disease. Its approved products include ZEJULA, VYVGART, NUZYRA, OPTUNE, QINLOCK, XACDURO, and AUGTYRO, which it sells primarily in mainland China, Hong Kong, Macau, and Taiwan. The company operates through subsidiaries in China, Hong Kong, Taiwan, Australia, and the United States, and partners with global pharmaceutical firms to develop and market its products.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Zai Lab Ltd (ZLAB)
What Is the Price Target for ZLAB?
SEPT Low Target
$45.00
SEPT Mid Target
$45.00
SEPT High Target
$45.00
Analyst Consensus
$45.00
Is ZLAB a Buy or Sell Right Now?
Thesis
- •Revenue growing 15.3% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ZLAB.
Start Free Trial →Is ZLAB Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$45.00
20
Moat Score
NONE
3/9
Piotroski Score
28.8
Altman Z-Score
What Is Smart Money Doing with ZLAB?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chen Yajing | officer | Buy | 920 | - | Oct 1, 2026 |
| Chen Yajing | officer | Sale | 315 | $8K | Oct 1, 2026 |
| Du Ying | director officer | Sale | 33,993 | - | May 27, 2026 |
| Du Ying | director officer | Sale | 53,850 | - | May 27, 2026 |
| Du Ying | director officer | Sale | 19,857 | - | May 26, 2026 |
| Du Ying | director officer | Buy | 261,092 | $454K | May 19, 2026 |
| Du Ying | director officer | Sale | 117,435 | $2.2M | May 19, 2026 |
| Du Ying | director officer | Buy | 50,000 | $87K | May 18, 2026 |
| Du Ying | director officer | Sale | 50,000 | $950K | May 18, 2026 |
| Du Ying | director officer | Buy | 50,000 | $87K | May 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ZLAB Growth Story
Revenue YoY
15.3%
3yr Revenue CAGR
28.9%
EPS Growth YoY
38.46%
FCF Growth YoY
27.9%
Revenue Trend
STRONG
Dark Pool Trades for ZLAB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ZLAB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:11 | $26.04 | 1,187 | $$31K | SELL |
| 20:41:18 | $26.19 | 1,205 | $$32K | BUY |
| 19:43:14 | $26.34 | 2,495 | $$66K | SELL |
| 16:37:30 | $26.25 | 2,000 | $$53K | SELL |
| 15:45:37 | $26.30 | 1,000 | $$26K | SELL |
5 dark pool trades shown · $$207K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Zai Lab Ltd (ZLAB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ZLAB — frequently asked questions
What is ZLAB stock price today?
Zai Lab Ltd (ZLAB) is at $26.04, down 1.44% (-$0.38) at the Nov 12, 2026 close.
Why is ZLAB stock moving today?
Latest ZLAB news — Nov 5, 2026: Zai Lab Ltd filed a report on a major company event (Form 8-K) · Nov 5, 2026: Zai Lab posts narrower quarterly loss as revenue tops estimates
What is the ZLAB price target?
The average analyst price target for ZLAB is $45.00, ranging from $45 to $45, based on 1 analysts. Latest: Citigroup maintains on Aug 7, 2026.
What do analysts rate ZLAB?
Analyst ratings for ZLAB: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did ZLAB beat earnings?
ZLAB last reported on Aug 6, 2026: EPS -$0.46 vs -$0.06 expected — a miss of 666.7%.
Does ZLAB pay a dividend?
ZLAB does not currently pay a dividend.
What are ZLAB support and resistance levels?
Support: $25.50, $23.71, $21.42. Resistance: $27.14, $29.02.
What are insiders doing with ZLAB?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on ZLAB?
Nov 5, 2026: Zai Lab Ltd filed a report on a major company event (Form 8-K) · Nov 5, 2026: Zai Lab posts narrower quarterly loss as revenue tops estimates